
CAS 1375064-29-1
:17α-Methyl-5α-androstane-2β,3α,17β-triol
Description:
17α-Methyl-5α-androstane-2β,3α,17β-triol, identified by its CAS number 1375064-29-1, is a synthetic anabolic steroid that is structurally related to testosterone. This compound features a modified steroid backbone, characterized by the presence of a methyl group at the 17α position and hydroxyl groups at the 2β, 3α, and 17β positions. These modifications influence its biological activity, enhancing anabolic properties while potentially reducing androgenic effects. The compound is often studied for its effects on muscle growth and performance enhancement, making it of interest in both medical and athletic contexts. Its solubility and stability can vary based on the specific formulation and conditions, and it may exhibit different pharmacokinetic profiles compared to natural steroids. As with many anabolic steroids, there are concerns regarding its potential for misuse and associated health risks, including hormonal imbalances and cardiovascular issues. Research into its safety and efficacy continues, particularly in relation to its therapeutic applications and regulatory status in sports.
- 17α-Methyl-5α-androstane-2β,3α,17β-triol
- 17α-Methyl-5α-androstane-2β,3α,17β)-triol
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
17α-Methyl-5α-androstane-2β,3α,17β-triol
CAS:Controlled Product<p>Please enquire for more information about 17α-Methyl-5α-androstane-2β,3α,17β-triol including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C20H34O3Purity:Min. 95%Molecular weight:322.5 g/mol17alphalpha-Methyl-5α-androstane-2β,3α,17β)-triol-d3
CAS:Controlled ProductFormula:C20D3H31O3Color and Shape:NeatMolecular weight:325.50117α-Methyl-5α-androstane-2β,3α,17β)-triol
CAS:Controlled Product<p>Applications 17α-Methyl-5α-androstane-2β,3α,17β)-triol is a derivative of Madol (M108000, which is an anabolic steroid recently identified to be misused as a doping agent. The potency of Madol (DMT) to transactivate androgen receptor (AR) dependent reporter gene expression was two times lower as compared to dihydrotestosterone (DHT).<br>References Zierau, O., et al.: Planta Med., 69, 856 (2003), Takahashi, M., et al.: Endocr. J., 51, 425 (2004), Labrie, F., et al.: J. Endocrinol., 184, 427 (2005),Friedel, A., et al.: Toxicol. Lett., 164, 16(2006),<br></p>Formula:C20H34O3Color and Shape:NeatMolecular weight:322.48

